Indian drugmaker Dr Reddy’s shares slide after Q3 profit miss
(Reuters) -Shares of Dr Reddy’s Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine months, after missing its third-quarter profit estimates on lower sales and pricing pressures in the key North American market. The generic drugmaker was the top loser on the Nifty Pharma index and the benchmark …
Indian drugmaker Dr Reddy’s shares slide after Q3 profit miss Read More »







